In this webinar we will cover the history and content of the NIOSH List of Antineoplastic and Other Hazardous Drugs (HDs) in Healthcare Settings, and USP Chapter <800> as it applies to all pharmacies. Additionally, we will discuss in more detail the requirements and process for a pharmacy to list HDs in stock and for performing a risk assessment. We will also review the physical requirements of the pharmacy, personal protective equipment (PPE), and staff training requirements.
Following the webinar, participants will have learned to:
- Review the history and content of USP Chapter <800> and the NIOSH List of Antineoplastics and Other Hazardous Drugs in Healthcare Settings.
- Describe the process to construct an HD list and perform HD risk assessments for your pharmacy.
- Define the key engineering controls required for compliance with USP Chapter <800>.
- Review the types and specifications of the personal protective equipment required when handling HDs.
- List the elements required in your hazardous drug staff training program.
Presenter: Denise Frank, BPharm, RPh, Principal Frank Consulting, LLC
Denise Frank is a pharmacist with 30+ years of experience, and currently an independent consultant in the areas of pharmacy practice, technician training, compounding, pharmacy and wholesaler accreditations, and operational and regulatory compliance. She is also a former member of the Minnesota Board of Pharmacy.
Previously serving as a surveyor and then the Accreditation and Inspection Services Manager for NABP, her responsibilities included development and maintenance of accreditation and inspection programs, and supervising NABP inspectors. Prior to this, she was an independent pharmacy owner, worked for a health-system, and was a pharmacy manager and district manager for a pharmacy chain.
Free for MPhA members and $25 for nonmembers. Student pharmacists and residents are provided a complimentary registration.
Student pharmacists and residents are provided a complimentary registration, please use the promo code “WebinarComp16” when checking out.
This presentation is being submitted to the Minnesota Board of Pharmacy for Continuing Education credit approval (one hour).
To receive Board of Pharmacy credits for this program the following must be completed:
Board of Pharmacy credit processing takes place on the 15th of each month.
||The Minnesota Pharmacists Association is accredited by the Minnesota Board of Pharmacy as a provider of continuing pharmacy education.
Questions? Please contact email@example.com with questions about credits.
Please contact firstname.lastname@example.org with any technical questions or issues.